4 marks against wrong questions for GujCET aspirants

Gujarat Secondary and Higher Secondary Education board It has been decided by the Gujarat Secondary and Higher Secondary Education board (GSHSEB) to award four marks against the four wrong questions to the students who wrote their Gujarat Common Entrance Test (GujCET) for admission to medical and para-medical courses. This decision comes in the backdrop where the board found that two questions in physics and two in biology were wrong. Board officials have clarified that those students who wrote GujCET will be given four marks against the four wrong questions. Earlier, the board had announced to give two marks — one each in physics and biology.

Media reports state that GSHSEB had received 405-odd objections to the answer keys for GujCET. After this, the board sought experts’ opinion and decided to give one mark against each of the four wrong questions. While declaring the provisional answer key, the board had said that it would prepare the merit list on the basis of marks scored out of total 117, instead of 120, as it said three questions were wrong. Later, it announced that only two questions were wrong. But finally, it settled with the decision that four questions were wrong and so merit would be calculated on the basis of marks obtained out of 120.

Meanwhile, Gujarat University (GU) has begun online admissions for the 2,800 seats in seven science colleges in the city, barring St Xavier’s College. GU stated that students seeking admission to first year BSc courses will have to apply online, while allotment of seats at these colleges will be offline. GU has decided to call 500 students every day and will allocate seats according to merit from June 20 to June 27.

"Exciting news! Elets Education is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.